Effects of propofol on functional activities of hepatic and extrahepatic conjugation enzyme systems

Ta-Liang Chen, Chih-Hsiung Wu, Tyng-Guey Chen, Yu-Ting Tai, Huai-Chia Chang, Chih Lin

研究成果: 雜誌貢獻文章同行評審

25 引文 斯高帕斯(Scopus)


The effect of propofol on the hepatic and extrahepatic conjugation enzyme systems was assessed in vitro using microsomal and cytosolic preparations of human liver, hamster kidney, lung and gut. The functional activities of phase-II enzymes, including uridine diphosphate-glucuronosyltransferase (UDPGT), glutathione S-transferase (GST) and N-acetyltransferase (NAT) were evaluated in the presence of various concentrations of propofol (0.05-1.0 mmol litre-1), using 1-naphthol, 1-chloro-2,4-dinitrobenzene and p-aminobenzoic acid as substrates respectively. Propofol produced concentration-dependent inhibition of UDPGT activity in human liver microsomes. Propofol did not produce significant inhibition of human hepatic GST activity at concentrations below 1.0 mmol litre-1. In contrast, NAT activity was unaffected by propofol 0.05-1.0 mmol litre-1 in human liver cytosolic preparations. In extrahepatic tissues, hamster renal and intestinal UDPGT activities were significantly inhibited by propofol at 0.25-1.0 mmol litre-1. In these tissues, GST and NAT were unaffected by propofol at 1.0 mmol litre-1. Propofol produced differential inhibition of human liver and hamster extrahepatic conjugation enzymes as a result of different substrate and tissue specificities. The potential interference of the metabolic profile of phase-II enzymes as a result of inhibition by propofol (especially of UDPGT and GST) should be considered when using propofol with other drugs for anaesthesia.
頁(從 - 到)771-776
期刊British Journal of Anaesthesia
出版狀態已發佈 - 6月 2000

ASJC Scopus subject areas

  • 麻醉與疼痛醫學


深入研究「Effects of propofol on functional activities of hepatic and extrahepatic conjugation enzyme systems」主題。共同形成了獨特的指紋。